GHK-Cu
Copper tripeptide (Gly-His-Lys-Cu)
GHK-Cu is a naturally occurring copper-binding tripeptide (glycyl-L-histidyl-L-lysine + copper) first found in human plasma — and one of the most researched peptides in skin science. It's studied for collagen production, skin regeneration, wound healing and hair, and it comes in two very different forms: topical (cosmetic) and injectable (research). This guide covers how GHK-Cu works, what the research actually shows, topical vs injectable use, dosing references, safety and legal status.
GHK-Cu quick facts
| Reported research dosing | 1mg-5mg |
| Route | Subq |
| Cycle length | - |
| Frequency | 1-2x Daily Am and PM · 5 On 2 Off or Daily |
| Half-life | Variable (topical bioavailability varies) |
| Forms | Injectable, Oral, Topical |
| Evidence level | In-vitro + topical human |
Skin, hair and repair. Watch copper balance if you run it long-term.
How GHK-Cu works
GHK-Cu is essentially a signal for tissue remodeling. It carries copper — a required cofactor for the enzymes that build and remodel the extracellular matrix — and at very low (nanomolar) concentrations it stimulates the synthesis of collagen, elastin and glycosaminoglycans, while also balancing the matrix-metalloproteinases and their inhibitors (TIMP-1/TIMP-2) that break tissue down. Beyond that, GHK acts as an epigenetic regulator: research shows it influences the expression of hundreds of genes tied to wound repair, antioxidant defense and inflammation control.
What the research shows & benefits
Skin & collagen. This is GHK-Cu's strongest evidence. Lab studies show it can raise collagen production substantially, and in a human trial comparing topical GHK-Cu to vitamin C and retinoic acid, GHK-Cu increased collagen in about 70% of volunteers — outperforming both.
Wound healing. Across animal models (rats, mice, rabbits, pigs) GHK-Cu accelerates wound closure, improves skin-graft integration, and increases angiogenesis and antioxidant enzyme levels.
Hair. GHK is used to support hair-follicle health and improve hair-transplant outcomes; results vary and the hair evidence is less mature than the skin evidence.
Topical vs injectable GHK-Cu
GHK-Cu is unusual in that it's both a cosmetic ingredient and a research injectable. Topically, it's widely used in serums and creams (commonly 1–4% concentrations) for skin firmness, texture and fine lines — the best-supported, lowest-risk way to use it. Injectable GHK-Cu is used in research and some clinical settings for more systemic skin/tissue goals, but it carries the usual research-compound cautions and should only be handled by qualified professionals. For most people interested in skin, the topical route is where the human evidence is strongest.
GHK-Cu dosing (research reference)
Topical: the literature commonly references 1–4% GHK-Cu concentrations, with skin-texture improvements often reported within 2–4 weeks and collagen/firmness changes over 8–12 weeks of consistent use. Injectable: research references a roughly 1–3 mg/day subcutaneous range, often starting lower and titrating up, reconstituted with bacteriostatic water — the calculator above converts a research amount into syringe units. Injectable use should only be set by a qualified provider. This summarizes existing references for education only, not as a recommendation for human use.
Safety & side effects
Topical GHK-Cu is generally very well tolerated, with irritation being the main occasional issue. Injectable GHK-Cu has far less human safety data; because copper is biologically active, dose matters, and quality/purity in the research market varies — a Certificate of Analysis and professional oversight are important. As always, this is educational information, not medical advice.
Related compounds & stacking
GHK-Cu is a common partner to the healing peptides — it's the collagen/skin arm of blends like GLOW and KLOW, which pair it with BPC-157 and TB-500 for a combined skin-and-recovery approach.
Legal & regulatory status
Topical GHK-Cu is a legal, widely-sold cosmetic ingredient. Injectable GHK-Cu is not FDA-approved and is offered as a research compound (research use only); its compounding status, like other peptides, is subject to ongoing FDA review. Follow the laws that apply to you.
✅ Clinically validated
- The topical human evidence is real and it is the best-supported claim on this page. Controlled trials of copper-peptide creams show measurable improvements in skin density, fine lines and wound healing — which is why GHK-Cu is a mainstream cosmetic ingredient rather than a research chemical.
- There are no human trials of injected GHK-Cu for any systemic endpoint.
📊 Correlative data
- Plasma GHK-Cu falls sharply with age — roughly 200 ng/mL at 20 down to about 80 by 60 — which is an observation about human biology rather than about supplementation, and it is the origin of the whole systemic-use idea.
- Injected use is reported for hair, skin and connective tissue. It reliably causes a local reaction at the injection site, which is the most consistent thing in the anecdotal record.
🧪 Theoretical / extrapolated
- A copper-carrying tripeptide that modulates gene expression broadly — published transcriptomic work shows it shifts expression of a very large number of genes toward a repair-associated pattern.
- The copper is the mechanism and also the limit. It works by delivering copper into cells, so systemic dosing has a ceiling that topical use does not: copper is tightly regulated in the body for good reason, and more signalling is not straightforwardly better.
These tiers tell you how much human evidence exists — not how well something works. This is the research space, and most of what’s in here is new rather than disproven. Something sitting at “theoretical” usually means nobody has funded the trial, not that the trial was run and failed.
The trap runs the other way too: something can be clinically validated and still do very little for you specifically. A statistically significant result in a study population is not a promise about your body.
- ✅ Clinically validated — human randomised trials or meta-analyses support it. The strongest footing available.
- 📊 Correlative — observational or epidemiological data. Suggestive, and genuinely useful for direction, but it cannot establish cause.
- 🧪 Theoretical / mechanistic — the mechanism is understood and often demonstrated in cells or animals, and the human trial doesn’t exist yet. Unproven is not the same as ineffective. Plenty of what’s standard practice today sat here five years ago.
✗ is a safety flag, not a grade. Where you see it, the concern is harm — not a disappointing trial. A compound tested for one purpose and found not to help there can still be worth studying somewhere else, so a negative result never gets rendered as a cross. It sits alongside the tier, because something can be both well-studied and genuinely risky.
My job is to tell you which one you’re looking at, and let you make the call. Grading something low isn’t me dismissing it — it’s me refusing to oversell it. This is the research space, and being able to reason forward from a mechanism matters as much as waiting for the trial.
GHK-Cu — safety, predicted from mechanism
Much of this compound class has never been through a human safety trial. Rather than say nothing — or print a generic warning — this is what its known mechanism predicts could go wrong, and what you can do about it. Predictions are labelled as predictions.
What the mechanism predicts
Derived from what this molecule does, not from a trial.
- The copper is the active ingredient and also the constraint. Copper is an essential trace mineral with a genuine upper limit, and these deliver it directly.
- Topically over a small area this is not a systemic concern. Large surface areas, high concentrations, or injecting it are a different proposition — the same molecule at a different exposure.
What has actually been reported
- Topical use is well tolerated; irritation and temporary blue-green staining are the common complaints, both cosmetic.
How to reduce the risk
Each of these follows from the same mechanism as the prediction.
- Match the exposure to the goal. A face-sized area of a topical is a different proposition from full-body use or injection. Most of the cosmetic benefit is local, so there is rarely a reason to escalate to systemic exposure for a skin outcome.
- Keep it away from direct vitamin C in the same layer. Copper and ascorbic acid deactivate each other — this wastes both rather than harming you, but it is the most common way people get nothing from an expensive product. Vitamin C in the morning, copper at night.
- Don't stack multiple copper products at once. A copper serum, a copper shampoo and a copper body lotion are three doses of the same mineral, and the ceiling is on the mineral, not on the product.
- If you are injecting it or covering large areas long-term, serum copper and ceruloplasmin are the two markers that would actually show accumulation.
What it does to your bloodwork
A fact about the assay, not a guess about the drug.
- If you are using this at scale or injecting it, serum copper and ceruloplasmin are the markers that would show accumulation.
Don't run this if
- Wilson's disease or any condition of copper handling — the mechanism is delivering the exact thing you cannot clear.
The honest unknown
- Cumulative copper load from long-term high-surface-area topical use has not been characterised.
Not medical advice. If you take prescription medication or have a diagnosed condition, check this with a pharmacist or doctor.
Close to the tissue, and consistency beats the clock
A brief exposure starts a process that runs for days, so the hour you dose is a minor variable — missing days is the one that costs you. Where the target is local, dosing near the site is worth more than any timing choice.
Derived from half-life, route and mechanism — not from a dosing trial. Reasoned, and labelled as reasoned.
GHK-Cu reconstitution calculator
Research reconstitution calculator
Where to get GHK-Cu
Buy GHK-Cu at AminoWell USA →GHK-Cu — interference & stacking
Predicted from mechanism, not from an interaction study. There are no trials of these combinations — what follows is what the biology implies, so treat it as a reason to watch something, not as a finding.
What GHK-Cu moves on your bloodwork
These are the markers this compound is expected to move, and which direction. Knowing that in advance is mostly about NOT panicking: some of these moving is the compound working.
- Copper, Serum — ↑ expected to rise
Only relevant at systemic doses — topical use does not meaningfully raise serum copper.
What to do: Not routinely needed. It matters if you are injecting it regularly or already have a copper-handling condition. - Ceruloplasmin — ◆ worth watching
The copper-carrying protein, and the one that tells you whether copper is bound and safe or free and reactive.
What to do: Read with serum copper, never alone. - Zinc, Plasma — ↓ expected to fall
Copper and zinc compete for absorption. Sustained copper loading predicts falling zinc, which then shows up as immune and taste changes that get blamed on something else.
What to do: If you are running copper systemically for months, check zinc.
- Which compounds push the same lever, and why the dose adds up faster than people count
- What blunts it — the stacks that waste your money
- What compounds the risk, so a side effect arrives sooner than any one of them suggests
- Coach Cam's read on running it alongside the rest of your protocol
Get the complete breakdown for GHK-Cu — inside the Academy alongside the full interactive Vault.
Unlock in the Academy — $10/mo →Bloodwork to run alongside GHK-Cu
Run these before you start, and again after 8–12 weeks. A baseline you didn’t take is one you can never go back for.
| Marker | What it’s watching for |
|---|---|
| Copper, Serum | It IS a copper peptide. Sustained use is a real copper-load question |
| Ceruloplasmin | The transport protein — read with copper or neither means much |
| Comprehensive Metabolic Panel (CMP) | Liver, which handles copper excretion |
| hs-CRP (High-Sensitivity C-Reactive Protein) | The inflammation and repair claim, measured |
The Heavy Metals & Mineral Balance panel covers these in one order — 7 markers, $270.90 with the discount applied.
Check results you already have → · All 102 markers A–Z
GHK-Cu — frequently asked questions
What is GHK-Cu?
GHK-Cu is a copper-binding tripeptide found naturally in human plasma, researched for collagen production, skin regeneration, wound healing and hair. It comes in topical (cosmetic) and injectable (research) forms.
How does GHK-Cu work?
It delivers copper needed for tissue-remodeling enzymes and stimulates collagen, elastin and glycosaminoglycan synthesis, while acting as an epigenetic regulator of genes tied to repair, antioxidant defense and inflammation.
Is topical or injectable GHK-Cu better?
For skin, topical GHK-Cu has the strongest human evidence and the lowest risk, and is a legal cosmetic ingredient. Injectable GHK-Cu is a research compound with less human safety data and should only be handled by qualified professionals.
How is GHK-Cu dosed?
Topical references commonly cite 1–4% concentrations; injectable research references roughly 1–3 mg/day subcutaneously, titrated and reconstituted with bacteriostatic water (see the calculator above). This is educational, not dosing advice.
Does GHK-Cu really boost collagen?
Research is supportive: lab studies show substantial collagen increases, and a human trial found topical GHK-Cu raised collagen in about 70% of volunteers, outperforming vitamin C and retinoic acid.
Is GHK-Cu FDA-approved?
Topical GHK-Cu is a legal cosmetic ingredient. Injectable GHK-Cu is not FDA-approved and is sold as a research compound, with compounding status under ongoing review.
References & further reading
- GHK peptide as a modulator of skin-regeneration pathways (PMC review)
- Skin-regenerative and anti-cancer actions of copper peptides (Cosmetics, MDPI)
- GHK-Cu for collagen & skin regeneration — mechanism overview
Want Coach Cam's exact GHK-Cu protocol?
Dosing schedules, stacking, cycle timing and my personal notes live inside the Academy — plus the full interactive Vault of 237 compounds & 350 supplements.
Join the Academy — $10/mo →What GHK-Cu is used for
GHK-Cu appears under 2 goals in the Vault’s goal router, grouped by the mechanism it works through rather than by how much trial evidence exists. Each link opens that pathway in full, with the alternatives beside it and the bloodwork that tests it.